AngioDynamics, Inc. ANGO recently announced the completion of the sale of its PICC and Midline product portfolios to Spectrum Vascular for $45 million in cash. AngioDynamics' PICC, Midline, and tip ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. today announced FDA clearance of its HydroMID™ midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has ...
The incidence of catheter-related bloodstream infections was low in patients with midline vs peripherally inserted central catheters, but the use of midline catheters was associated with increased ...
Use of an extended-dwell peripheral IV catheter to reduce costs and increase patient safety and comfort will be the subject of several poster and oral presentations at the upcoming Annual Scientific ...
LATHAM, N.Y. - Medical technology firm AngioDynamics , Inc. (NASDAQ: NASDAQ: ANGO) has divested its peripherally inserted central catheter (PICC) and Midline product lines to Spectrum Vascular for a ...
University of Utah Health’s Vascular Access (PICC) Team is a team of health care professionals specially trained in vascular access—or putting catheters inside your blood vessels so your body can get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results